LegCo Secretariat releases Policy Pulse on "Developing an international health and medical innovation hub: Reform of medical products and inheritance of Chinese medicine"
The following is issued on behalf of the Legislative Council Secretariat: The Legislative Council (LegCo) Secretariat today (October 26) released the latest issue of the Policy Pulse on "Developing an international health and medical innovation hub: Reform of medical products and inheritance of Chinese medicine", introducing Hong Kong's various measures to reform the regulatory regime for drugs and medical devices (medical products) and the latest progress in promoting the inheritance and innovation of Chinese medicine (CM), as well as summarising relevant discussions in LegCo and Members' recommendations. The Outline of the National 15th Five-Year Plan proposes to "advance biomedicine", "optimize the evaluation and approval mechanism for innovative drugs and drugs with urgent clinical use", whilst also supporting the promotion of CM culture and contributing to the building of a Healthy China. The Hong Kong's First Five-Year Plan proposes to establish a medical innovation hub with global influence, continue to comprehensively intensify the regulatory reform of medical products, make good drugs and medical devices available for use in Hong Kong, and step up efforts to promote CM dev
Free plan · Plus CA$29 or Pro CA$99/month


